Under the Securities Exchange Act of 1934
(Amendment No.  5)*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Name, Address, and Telephone Number of Person
Authorized to Receive Notices and Communications)

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 440.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

2

This Amendment No. 5 amends the Schedule 13D filed with the United States Securities and Exchange Commission on August 24, 2000, as most recently amended by Amendment No. 4 filed August 25, 2017 (the “Statement”) on behalf of the undersigned.  This Amendment No. 5 is being filed to report purchases of Common Stock (the “Common Stock”) of Retractable Technologies, Inc. (the “Company”), which purchases together represent a material increase in the percentage of Common Stock owned by the undersigned. Unless specifically amended hereby, the disclosure set forth in the Statement shall remain unchanged.

Item 3.  Source and Amount of Funds or Other Consideration.

Mr. Shaw acquired the stock using personal funds.  No part of the purchase price was borrowed.

Item 4. Purpose of the Transaction.

The purpose of the transactions is to acquire additional control of the Company.  All purchases were made pursuant to Rule 10b5-1 Plans.

Item 5.  Interest in Securities of the Issuer.

Item 5 of the Statement is amended and restated as follows:

(a)                                 As of the date hereof, Mr. Shaw has beneficial ownership of 18,493,386 shares which comprises 56.6% of the Common Stock of the Company.  There are 32,666,454 shares outstanding as of the date hereof.

(b)(i)                      Mr. Shaw has sole power to vote 1,770,000 shares of Common Stock standing in the name of the August 2010 Family Trust and 1,000,000 shares of Common Stock standing in the name of the August Gifting Trust, both holdings being subject to a Voting Agreement with his former spouse (the “Voting Agreement”).

(ii)                    Mr. Shaw has sole power to vote and dispose 13,893,386 shares of Common Stock standing in his name.

(iii)                 Mr. Shaw has sole power to dispose of a total of 1,500,000 shares of Common Stock standing in the names of three trusts for which he serves as trustee for the benefit of each of his three children.

(c)                                  Below is a table showing all transactions effected by Mr. Shaw’s stockbroker under Mr. Shaw’s Rule 10b5-1 Plan during the last 60 days.  All purchases set forth below are open market purchases previously disclosed on Form 4s filed pursuant to Section 16(a) of the Securities Exchange Act of 1934.  As disclosed in such Form 4s, some of the prices set forth below represent the weighted average per share price of various purchases during a single day.  Mr. Shaw will provide to the SEC full information regarding the number of shares purchased at each price upon written request.

3

(d)                                 The August 2010 Family Trust and the August Gifting Trust (and the beneficiaries thereof) shall have the right to receive dividends from, or the proceeds from the sale of, the shares identified in Item (b)(i) of this Item 5.  The three trusts identified in Item (b)(iii) of this Item 5 (and the beneficiaries thereof) shall have the right to receive dividends from, or the proceeds from the sale of, 500,000 shares of Common Stock each.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

4